New antiretroviral agents
Roca, B.; Simón, E.
Anales de Medicina Interna 15(11): 606-614
1998
ISSN/ISBN: 0212-7199 PMID: 9882861 Document Number: 492268
In the last years significant advances in the knowledge of all aspects of HIV infection have happened. It is especially important that the new kinds of treatment against the virus have substantially improved the prognosis of the infection. The available antiretrovirals belong to three groups: nucleoside reverse transcriptase inhibitors, non nucleoside reverse transcriptase inhibitors, and protease inhibitors. We review the characteristics of the most recently developed drugs.
Document emailed within 1 workday
Related Documents
Martínez, E.; Gatell, J.M. 1999: Lipodystrophy and antiretroviral agents Revista Clinica Espanola 199(8): 485-486Lange, J.M.A.; Ananworanich, J. 2014: The discovery and development of antiretroviral agents Antiviral Therapy 19 Suppl. 3: 5-14
Buss, N.; Cammack, N. 2001: Measuring the effectiveness of antiretroviral agents Antiviral Therapy 6(1): 1-7
Engebretsen, I.M.S.; Tylleskär, T. 2010: HIV, breast feeding and antiretroviral agents Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 130(5): 520-522
Horsmans, Y.; Larrey, D.; Pessayre, D.; Benhamou, J.P. 1990: Hepatotoxicity of antimicrobial agents. II: Urinary antiseptics, antitubercular agents, antiparasitic agents, antifungal agents, antiviral agents Gastroenterologie Clinique et Biologique 14(12): 919-924
Burger, D.M.; Hoetelmans, R.M.; Koopmans, P.P.; Meenhorst, P.L.; Mulder, J.W.; Hekster, Y.A.; Beijnen, J.H. 1997: Clinically relevant drug interactions with antiretroviral agents Antiviral Therapy 2(3): 149-165
Martins, C.R. 2006: Cutaneous drug reactions associated with newer antiretroviral agents Journal of Drugs in Dermatology: Jdd 5(10): 976-982
Groopman, J.E. 1991: Treatment of AIDS with combinations of antiretroviral agents: a summary American Journal of Medicine 90(4a): 27S-30S
Acosta, E.P.; Gerber, J.G. 2002: Position paper on therapeutic drug monitoring of antiretroviral agents AIDS research and human retroviruses 18(12): 825-834
Sinet, M.; Pocidalo, J.J. 1993: Are immunomodulators capable to improve the activity of nucleoside antiretroviral agents? Pathologie-Biologie 41(8 Part 2): 794-798
El-Beitune, P.; Duarte, G.; de Morais, E.N.; Campbell, O.; Spara-Gadelha, P.; Mauad-Filho, F.; Quintana, S.M.; Rodrigues, L.C. 2007: Antiretroviral agents and acid-base balance at delivery of the neonate Brazilian Journal of Medical and Biological Research 40(7): 957-961
Achan, J.; Kakuru, A.; Ikilezi, G.; Ruel, T.; Clark, T.D.; Nsanzabana, C.; Charlebois, E.; Aweeka, F.; Dorsey, G.; Rosenthal, P.J.; Havlir, D.; Kamya, M.R. 2012: Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children New England Journal of Medicine 367(22): 2110-2118
1997: Guidelines for the use of antiretroviral agents in pediatric HIV infection--HRSA. Request for comments Federal Register 62(189): 51115-51116
Kojima, E.; Shirasaka, T.; Machida, M.; Yoshioka, H.; Murakami, K.; Mitsuya, H. 1991: Synthesis and structure-activity relationships of 2',3'-dideoxypurine nucleosides as potential antiretroviral agents Nucleic Acids Symposium Series 25: 91-92
Uneke, C.J.; Ogbonna, A. 2008: Malaria and HIV co-infection in pregnancy in sub-Saharan Africa: impact of treatment using antimalarial and antiretroviral agents Transactions of the Royal Society of Tropical Medicine and Hygiene 103(8): 761-767
Antinori, A.; Marcotullio, S.; Andreoni, M.; Chirianni, A.; d'Arminio Monforte, A.; Di Biagio, A.; Galli, M.; Mazzotta, F.; Mussini, C.; Puoti, M.; Lazzarin, A.; Adriana, A.; Gioacchino, A.; Orlando, A.; Sergio, B.; Teresa, B.; Paolo, B.; Stefano, B.; Marco, B.; Michele, B.; Raffaele, B.; Maria Rosaria, C.; Roberto, C.; Emilia-Romagna, R.; Andrea, C.; Antonella, C.; Francesco, C.; Maria, C.Anna.; Roberto, C.; Alessandra, C.; Antonella, C.; Paola, C.; Maria, C.Giulio.; Gabriella, D.Carli.; Andrea, D.Luca.; Giovanni, D.Perri. 2016: Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2015 New Microbiologica 39(2): 93-109
Monteny, M.; Kroes, A.C.; Groeneveld, P.H.; Kroon, F.P. 1998: Virological evaluation of the treatment of HIV-infected patients with (combinations of) antiretroviral agents in the Academic Medical Center of Amsterdam Nederlands Tijdschrift Voor Geneeskunde 142(20): 1169-1170
Muhamadi, L.; Nsabagasani, X.; Tumwesigye, M.Nazarius.; Wabwire-Mangen, F.; Ekström, A-Mia.; Peterson, S.; Pariyo, G. 2010: Inadequate pre-antiretroviral care, stock-out of antiretroviral drugs and stigma: policy challenges/bottlenecks to the new WHO recommendations for earlier initiation of antiretroviral therapy (CD<350 cells/microL) in eastern Uganda Health Policy 97(2-3): 187-194
1998: Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services and the Henry J. Kaiser Family Foundation Annals of Internal Medicine 128(12 Pt 2): 1079-1100
Lubega, M.; Tumwesigye, N.M.; Kadobera, D.; Marrone, G.; Wabwire-Mangen, F.; Peterson, S.; Reynolds, S.J.; Ekström, A.M. 2015: Effect of Community Support Agents on Retention of people Living with HIV in Pre-antiretroviral Care: a Randomized Controlled Trial in Eastern Uganda Journal of Acquired Immune Deficiency Syndromes 70(2): E36-E43